Show simple item record

FieldValueLanguage
dc.contributor.authorAlmoyad, Muhammad
dc.date.accessioned2018-05-08
dc.date.available2018-05-08
dc.date.issued2018-01-17
dc.identifier.urihttp://hdl.handle.net/2123/18161
dc.description.abstractColorectal cancer is the second most common cancer in women and third in men, accounting for 9.7 % of all cancers incidence. Oxaliplatin is a platinum-based anticancer drug used typically in combination with folinic acid and 5-fluorouracil for treatment against colorectal cancer. However, numerous side effects such as nausea and vomiting, GI toxicity, anaemia, immunodeficiency, ototoxicity, nephrotoxicity, and neurotoxicity are associated with its use. These can be decreased by lowering dose of oxaliplatin. Phytochemicals that can act as antioxidants have been used by people in treatment against cancer throughout human history because of their low toxicity and the ease in availability. Besides providing protection against cancer, they can also kill cancer cells. Studies show that chemopreventive agents would boost activity of anticancer drugs and thus improve treatment outcome. In this study, resveratrol, thymoquinone, capsaicin and quercetin were applied to four human colorectal cancer cell lines HT-29, Caco-2, Lim-1215 and Lim-2405 in combination with platinum drugs cisplatin and oxaliplatin using three sequences of administration (0/0 h, 0/4 h and 4/0 h). Activity of compounds alone and in combination were determined using MTT reduction assay. Combination index was used as a measure of combined drug action. Studies on cellular accumulation, platinumDNA binding, DNA damage and proteomics were carried out to obtain mechanistic insights. In HT-29 cell line all sequences of administration produced antagonism at lower concentration (ED50). In Caco-2 cell line, bolus combination of cisplatin with resveratrol was found to produce moderate synergistic effect at all concentrations. In Lim-2405 cell line, combination of cisplatin with quercetin was found to produce most synergistic outcome. As applied to oxaliplatin, its combination with quercetin was found to produce most synergistic outcomes in Caco-2 cell line. Combination of oxaliplatin and capsaicin was most synergistic in Lim-2405 cell line. Results on PtDNA binding showed that synergistic effect was associated with higher platinumDNA binding. In proteomics study, 16 proteins belonging to different functional groupings were found to undergo changes in expression as a result of treatment with synergistic combinations.en_AU
dc.rightsThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
dc.subjectColorectal canceren_AU
dc.subjectplatinum drugsen_AU
dc.subjectdrug resistanceen_AU
dc.subjectcombination indexen_AU
dc.subjectIC50 valueen_AU
dc.subjectproteomicsen_AU
dc.titleSynergism from combination of targeted therapy and phytochemicals in colorectal canceren_AU
dc.typeThesisen_AU
dc.type.thesisDoctor of Philosophyen_AU
usyd.facultyFaculty of Medicine and Health, Sydney Medical Schoolen_AU
usyd.departmentDiscipline of Biomedical Scienceen_AU
usyd.degreeDoctor of Philosophy Ph.D.en_AU
usyd.awardinginstThe University of Sydneyen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.